MedTrace Logo

Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care Treatment

NCT01421862 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2013-07-10

No results posted yet for this study

Summary

RATIONALE: Studying samples of bone marrow and blood from patients with cancer who failed treatment may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer resistance. It may also help doctors find better ways to treat cancer.

PURPOSE: This research trial studies biomarkers in samples from adult patients with acute myeloid leukemia who failed standard-of-care treatment.

Conditions

Interventions

GENETIC

DNA methylation analysis

GENETIC

RNA analysis

GENETIC

gene expression analysis

GENETIC

microarray analysis

GENETIC

mutation analysis

GENETIC

nucleic acid sequencing

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • Jerry Radich, MD · Fred Hutchinson Cancer Center

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2011-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01421862 on ClinicalTrials.gov